Literature DB >> 12918889

Establishing principles for migraine management in primary care.

A J Dowson1, J Sender, S Lipscombe, R K Cady, S J Tepper, R Smith, T R Smith, F R Taylor, G P Boudreau, N P van Duijn, A C Poole, V Baos, C Wöber.   

Abstract

Published guidelines for the management of migraine in primary care were evaluated by an international advisory board of headache specialists, to establish evidence-based principles of migraine management that could be recommended for international use. Twelve principles of migraine management were identified, covering screening, diagnosis, management and treatments: Almost all headaches are benign/primary and can be managed by all practising clinicians. Use questions/a questionnaire to assess the impact on daily living and everyday activities, for diagnostic screening and to aid management decisions. Share migraine management between the clinician and the patient. Provide individualised care for migraine and encourage patients to manage their migraine. Follow up patients, preferably with migraine calendars or diaries. Regularly re-evaluate the success of therapy using specific outcome measures and monitor the use of acute and prophylactic medications regularly. Adapt migraine management to changes that occur in the illness and its presentation over the years. Provide acute medication to all migraine patients and recommend it is taken at the appropriate time, during the attack. Provide rescue medication/symptomatic treatment for when the initial therapy fails. Offer to prescribe prophylactic medications, as well as lifestyle changes, to patients who have four or more migraine attacks per month or who are resistant to acute medications. Consider concurrent co-morbidities in the choice of appropriate prophylactic medication. Work with the patient to achieve comfort with mutually agreed upon treatment and ensure that it is practical for their lifestyle and headache presentation. Using these principles, practising clinicians can screen and diagnose their headache patients effectively and manage their migraine patients over the long-term natural history of the migraine process. In this way, the majority of migraine patients can be well treated in primary care, ensuring a structured and individualised approach to headache management, and conserving valuable healthcare resources.

Entities:  

Mesh:

Year:  2003        PMID: 12918889

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  9 in total

1.  Qualitative Development of the Rhinitis Control Assessment Test (RCAT), an Instrument for Evaluating Rhinitis Symptom Control.

Authors:  Robert A Nathan; Anand A Dalal; Richard H Stanford; Eli O Meltzer; Michael Schatz; Jennifer Derebery; Matthew Mintz; Michelle A Thompson; Dana B Dibenedetti
Journal:  Patient       Date:  2010-06-01       Impact factor: 3.883

2.  [Alimentary trigger factors that provoke migraine and tension-type headache].

Authors:  J Holzhammer; C Wöber
Journal:  Schmerz       Date:  2006-04       Impact factor: 1.107

Review 3.  [Non-alimentary trigger factors of migraine and tension-type headache].

Authors:  J Holzhammer; C Wöber
Journal:  Schmerz       Date:  2006-06       Impact factor: 1.107

4.  Headache: a 'suitable case' for behavioural treatment in primary care?

Authors:  Emmanouil K Symvoulakis; Lucy V Clark; Andrew J Dowson; Roger Jones; Leone Ridsdale
Journal:  Br J Gen Pract       Date:  2007-03       Impact factor: 5.386

Review 5.  Migraine headache: options for acute treatment.

Authors:  Frederick R Taylor
Journal:  Curr Neurol Neurosci Rep       Date:  2005-03       Impact factor: 5.081

6.  New uses of the Migraine Screen Questionnaire (MS-Q): validation in the Primary Care setting and ability to detect hidden migraine. MS-Q in Primary Care.

Authors:  Miguel J Láinez; Jesús Castillo; Manuel Domínguez; Gemma Palacios; Silvia Díaz; Javier Rejas
Journal:  BMC Neurol       Date:  2010-06-08       Impact factor: 2.474

7.  Randomized, double-blind, crossover study comparing DFN-11 injection (3 mg subcutaneous sumatriptan) with 6 mg subcutaneous sumatriptan for the treatment of rapidly-escalating attacks of episodic migraine.

Authors:  Roger K Cady; Sagar Munjal; Ryan J Cady; Heather R Manley; Elimor Brand-Schieber
Journal:  J Headache Pain       Date:  2017-02-07       Impact factor: 7.277

8.  Prophylaxis of migraine: general principles and patient acceptance.

Authors:  Domenico D'Amico; Stewart J Tepper
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

9.  Testing the Feasibility and Psychometric Properties of a Mobile Diary (myWHI) in Adolescents and Young Adults With Headaches.

Authors:  Anna Huguet; Patrick J McGrath; Michael Wheaton; Sean P Mackinnon; Sharlene Rozario; Michelle E Tougas; Jennifer N Stinson; Cathy MacLean
Journal:  JMIR Mhealth Uhealth       Date:  2015-05-08       Impact factor: 4.773

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.